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Abstract 
Monosaccharide-Responsive Polymers of Boronic acid Derivatives and Their Medical Applications, 
2013, Hyunkyu Kim, Graduate Program of Chemistry, Ulsan National Institute of Science and 
Technology (UNIST). 
 
Boroxole-containing styrenic monomer was synthesized from 3-bromo-4-
(bromomethyl)benzonitrile in seven steps and block copolymers of Poly(styreneboroxole) (PBOx) 
and poly(ethylene glycol) (PEG) were synthesized by the reversible addition−fragmentation and chain 
transfer (RAFT) method. The resulting amphiphilic block copolymer, PBOx-b-PEG, displayed 
binding to monosaccharides in phosphate buffer at neutral pH, as quantified by Wang’s competitive 
binding experiments. These block copolymers self-assembled into a variety of nanostructures 
including spherical and cylindrical micelles and polymer vesicles in water according to degree of 
polymerization of the PBOx block. The morphology of the self-assembled structures were observed 
on transmission electron microscopy (TEM) and dynamic light scattering (DLS), 
Polymersomes of these block copolymers exhibited monosaccharide-responsive disassembly in a 
neutral-pH medium. Disassembly of polymersomes was studied by UV-Vis spectrophotometer and 
DLS. These polymersomes stored fluorescein isothiocyanate (FITC)-labeled human insulin (F-
insulin) within the water-filled inner compartment. Encapsulation of F-insulin within polymersomes 
was confirmed by laser confocal fluorescence microscopy (LCFM). Encapsulated insulin could be 
released from the polymersomes only in the presence of sugars under physiological pH conditions. 
The result was verified by fluorescence intensity. 
Sequence-specific copolymer of styreneboroxole and N-functionalized maleimide was synthesized 
by RAFT polymerization method in the presence of a poly(ethylene glycol)-chain transfer agent. 
These polymers have a glucose receptor alternating with a nonresponsive solubilizing group 
throughout the sugar-responsive epolymer chain. This new system promotes further diffusion of 
glucose to bilayer membrane and essentially induces disassembly of the membrane into individual 
block polymers so these polymersomes become more sensitive to lower glucose concentrations than 
PBOx-b-PEG. It shows low cytotoxicity, serum compatibility, and sugar-responsive behavior at a 
glucose level close to physiologically relevant conditions that prove promising for controlled delivery 
applications for glucose-related diseases such as diabetes. 
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Chapter 1. Introduction 
 
1.1 Glucose-responsive polymer 
Many important substances in living systems respond to external stimuli and adapt themselves to 
changing conditions. Polymer scientists have been trying to mimic these behaviors and the interest of 
stimuli-responsive polymers has become increasingly for many decades. These polymers alter their 
physical and chemical properties in response to the external stimuli, so these polymers can be 
regulated in correspondence to the external stimuli, such as temperature, pH, light, and the presence of 
stimulant molecules1,2. Among stimuli-responsive polymers, the polymers that respond to glucose 
have considerable attention due to their promising application in both insulin delivery system and 
glucose sensing3. Not only diabetes is a chronic disease, but also the number of diabetics continues to 
increase. The most widely used method to control the blood sugar level is direct insulin injection and 
monitor the blood sugar level regularly. Two things give patients dangerousness and low compliance. 
One potential solution to solve the problems is the development of smart delivery system which 
regulates the blood sugar level automatically, so noticeable researches are 
are go along
going along 
nicely
to develop the self-regulated insulin 
delivery system based on glucose-responsive polymers. 
 
1.2 Boronic acid 
The organic molecules including B atoms are used in carbon-carbon bond formation reactions 
through transition-metal-catalyzed coupling so they are vital in developing the new organic materials 
with optical or electronic properties4.  The organoboronic acid has form of aromatic compounds 
containing boron atoms and typically acts as a Lewis acid due to the presence of the empty p orbital of 
the boron atom.  In 1954, Kuivila found phenylboronic acid forms boronate ester with 1, 2- or 1, 3- 
diol compound such as monosaccharide5 (Figure 1.1).  
 
 
Figure 1.1 Diol complexation equilibria of Phenylboronic acids (PBS) in aqueous Solution. 
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However, the form of boronate ester is in equilibrium and at neutral pH aqueous condition, hydrolysis 
of boronate esters is favored because of angle strain (120° → 108°). Therefore, through ionization 
boronate ester can be become to sp3 hybrid orbital and be stabilized in high pH condition (>9)6 (Figure 
1.1). These phenomena of organoboronic acids are available for the recognition of monosaccharide 
molecules in the aqueous solution. Therefore, it can be used as glucose sensor or insulin delivery 
materials so the development of polymeric materials with these properties has attracted a lot of 
attention in recent years.  
  
Figure 1.2 (A) Equilibria of (Alkylamido)phenyl boronic acid (B) Schematic illustration of glucose-
triggered swelling of hydrogel and release of FITC-insulin from the hydrogel at 28 °C, pH 9.07. 
 
Kataoka introduced monosaccharide cognitive function of organoboronic acid into polymer 
materials and pursued an investigationof it on the glucose sensor and insulin releasing materials for 
the first time7. He adopted phenyboronic acid at cross-linked acrylic acid polymer and synthesized 
hydrogels having a function of monosaccharide recognition (Figure 1.2 (a)). Phenylboronic acid 
3 
 
(PBA) in the cross-linked hydrogel binds to monosaccharides and then becomes ionized so the gel is 
swelled. At this time, encapsulated insulin in the gel is discharged to the outside by diffusion (Figure 
1.2 (b)). This first attempt proved that monosaccharide-responsive polymers can be synthesized 
through a way to change the physical properties of polymers and these hydrogels containing boronic 
acid can be used as the self-regulating insulin delivery materials.  
However, Boronate ester dominantly hydrolyze in aqueous solutions at neutral pH, so boronic acid-
containing polymers have been mainly used under high pH conditions (>9) that are incompatible for 
the use of these polymers under physiological conditions. 
 
 
Figure 1.3 A schematic representation of glucose-triggered disassembly of micelles of sugar-
responsive block copolymers8. 
 
 
Figure 1.4 A schematic representation of the polymer with monosaccharides in different pH 
environments. The photograph shows tubes containing the polymer  in different buffers after 18 h. 
Tube 1: 7 in PBS (pH ) 7.4), 2: in PBS/D-fructose (50 mM), 3: in PBS/D-glucose (100 mM), 4: in 
TRIS/ D-glucose (100 mM, pH ) 7.8)10. 
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The problem can be solved when boronate esters are stabilized in neutral aqueous solution by 
decreasing the pKa of the PBA.  The introduction of strongly electron-withdrawing substituents such 
as NO2, halogen, amide to the phenylboronic acid on meta and para position
8-10
 (Figure 1.3) and the 
introduction of an intramolecular electron sharing substituents such as dialkylaminomethyl, 
hydroxymethyl to phenylboronic acid on ortho position11,12 (Figure 1.4) can decrease the pKa of PBA 
so these methods make it possible to use boronic acid containing polymers under physiological 
conditions. Therefore, these materials have potentials in the areas of saccharide sensing and self-
regulating insulin delivery applications 
 
1.3 Well- Defined Copolymer  
To apply the unique properties of boronic acid-containing polymers efficiently to sensing or drug 
delivery system, it is important to synthesize well-defined copolymers with reliable molecular weights 
and narrow molecular weight distributions. Controlled radical polymerization is a synthetic method 
which controls these aspects. Atom transfer radical polymerization (ATRP)13-15 and Reversible 
addition-fragmentation chain transfer (RAFT)16-20 polymerization have been used to synthesize the 
well-defined boronic acid-containing polymers. Firstly, Jäkle et al. reported the efficient synthesis of 
monosaccharide responsive polymers using ATRP from the polymerization of organoboron 
monomers or silylated precursors21 (Sheme 1.1). Summerlin et al. employed RAFT polymerization 
and synthesized amphiphilic block copolymers firstly which can be self-assembled to micelles22 
(Scheme 1.2). However, because these polymers have the the pinacol ester, they need deprotection to 
have boronic acid-containing polymers after polymerization. 
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Scheme 1.1 Synthesis of the organoboron block copolymer PSBpin-b-PS by ATRP21. 
 
 
Scheme 1.2 Synthesis of boronic ester and boronic acid homopolymers and block copolymers by 
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RAFT polymerization22. 
1.4 Thesis Summary 
In Chapter 2, since the first synthesis of styrene-boroxole monomer, there have been progresses in 
the synthesis, block copolymer characterizations such as binding constant and self-assembly behavior 
conditions, and potential application of self-regulating insulin delivery system. Chapter 3 describes 
the synthesis and characterization of new type of sugar-responsive polymers that are based on a 
sequence-specific copolymer and shows the feasibility of using these polymersomes as drug delivery 
vehicles 
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Chapter 2. Monosacchride-Responsive Disassembly of Polymersomes of 
Polyboroxole Block Copolymers at Neutral pH 
 
2.1 Abstract  
We synthesized the boroxole-containing styrenic monomer that can be polymerized by radical 
addition-fragmentation and chain transfer (RAFT) method. Polystyreneboroxole (PBOx) and its block 
copolymers with a poly(ethylene glycol) (PEG) as a hydrophilic block showed monosaccharide 
binding in phosphate buffer at neutral pH, which was quantified by Wang's competitive binding 
experiments. Amphiphilic block copolymers having a monosaccharide-responsive PBOx block self-
assembled to polymersomes of which the average diameter was readily controllable by adjusting the 
number of boroxole units in the PBOx block via a controlled radical polymerization. These 
polymersomes also exhibited glucose-responsive disassembly at neutral pH. We demonstrated the 
possibility of using these polymersomes as glucose-responsive delivery vehicles for insulin at 
physiologically relevant pH medium. 
 
2.2 Introduction 
Polymersomes of amphiphilic block copolymers can store water-soluble cargos such as 
pharmaceutical molecules and polymers within the water-filled inner compartment.1−3 Because the 
membrane of polymersomes consists of high molecular- weight polymers, polymersomes exhibit 
physical and chemical robustness at the expense of reduced transmembrane permeability.4 Stimuli-
responsive block copolymers readily change their physical properties in response to external stimuli 
such as temperature, pH, and irradiation.5,6 The stimulated change of chemical and physical properties 
causes the vesicular membrane consisting of stimuli-responsive block copolymers to become 
permeable, resulting in release of the encapsulated cargo molecules from the polymersomes only 
when the appropriate stimulus is applied.7 Therefore, polymersomes made from the self-assembly of 
stimuli-responsive block copolymers are promising candidates for smart nanocontainers that can be 
used as drug delivery vehicles and bioreactors.8  
In this respect, of particular interest are polymers and block copolymers containing organoboronic 
acids, which bind reversibly to biologically important 1,2- and 1,3-diols such as monosaccharides and 
nucleotides.9,10 This binding switches the solubility of boronic acid-containing polymers from 
insoluble to soluble in water, which can be translated into the monosaccharide- triggered swelling of 
hydrogels and disassembly of micelles and polymersomes.11,12  Boronic acid-containing polymers, 
therefore, have been studied as candidate materials for sensors and drug delivery systems for sugar-
9 
 
related human diseases such as diabetes.13 Boronic acid−diol conjugates, however, easily hydrolyze in 
aqueous solutions at neutral pH, so boronic acid-containing polymers have been mainly used as sugar-
responsive materials under high pH conditions (>9) that are incompatible with in vivo studies and 
applications. This drawback can be overcome when the pKa of PBA is decreased using Wulff-type 
boronic acids14,15 and phenylboronic acids with electron withdrawing moieties.16 Hall and co-workers 
reported that the binding of phenylboroxole derivatives to glucose is superior to that of phenylboronic 
acids and Wulff-type boronic acids in aqueous solution at neutral pH.17 The increased binding of 
boroxole to glucose in water arises from the fact that boroxole binds to pyranose-form saccharides 
such as glucopyranoside, a major form of glucose in neutral aqueous solution. Kiser and co-workers 
recently reported boroxole-functionalized polymers that mimic lectins to bind glucoproteins.18 
However, well-defined self-assembling block copolymers containing polyboroxole as a saccharide-
responsive polymeric domain have not yet been synthesized.  
We report here the first synthesis of the boroxole-containing styrenic monomer 1 and its controlled 
radical polymerization via the reversible addition−fragmentation and chain transfer (RAFT) method. 
Synthesized poly(styreneboroxole) (PBOx) showed binding to monosaccharides in phosphate buffer 
at neutral pH (pH 7.4), which was quantitatively studied using Wang’s competitive binding assay.19 
By virtue of a controlled radical polymerization of 1, we synthesized a series of sugar responsive 
block copolymers that self-assembled to form polymersomes in water. We demonstrated that the 
polymersomes of these block copolymers could encapsulate water soluble cargo molecules such as 
insulin, which could then be released from the polymersomes only in response to the presence of 
monosaccharides in aqueous solution under physiological pH conditions (Figure 2.1) 
 
Figure 2.1 Self-assembly of PEG-b-PBOx and its disassembly in the presence of monosaccharides. 
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2.3 Results and Discussion  
 
Scheme 2.1 Synthesis of monomer 1 and its homopolymer and block copolymers by RAFT 
polymerization. 
 
Synthesis of the Boroxole-Containing Styrenic Monomer and Its Homopolymer and Block 
Copolymers. Styreneboroxole 1 was synthesized from 3-bromo-4- (bromomethyl)benzonitrile in 
seven steps in a moderate yield (Scheme 2.1).15,20 During the synthesis, the protecting group for 
benzyl alcohol was switched from a tert-butyldimethylsilyl (TBDMS) group to a methoxymethyl 
(MOM) group because of the difficulty in deprotection after addition of boronic acid. Hydrolysis of 
methylborate in the presence of HCl removed a MOM group from the monomer in situ, yielding a 
crystalline solid of 1  
For the polymerization of 1, we adopted a RAFT polymerization method using the trithiocarbonate 
chain transfer agent CTA-1 (Scheme 2.1).21 Under the standard conditions ([CTA]:[1]:[AIBN] = 
1:100:0.1) in tetrahydrofuran (THF) at 75 °C in a closed reaction vessel, RAFT polymerization of 1 
showed a near-linear increase of conversion over time up to ∼50% (Figure 2.2A). We also 
synthesized a series of amphiphilic block copolymers of PBOx by performing a RAFT polymerization 
of 1 with a poly(ethylene glycol) (PEG) based macro-chain-transfer agent (CTA-2, Scheme 2.1)22 in 
THF ([CTA]:[1]:[AIBN] = 1:100:0.2) at 75 °C. The polymerization was quenched when the degree of 
polymerization (DP) of 1 reached the required value, as monitored by 1H NMR integration of the 
reaction mixture. For all cases, the isolated yields of polymers and block copolymers after purification 
were 67−82% compared with the yield calculated by assuming the complete consumption of the 
chain-transfer agent. 
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Figure 2.2 (A) Time−conversion plot for polymerization of 1 under RAFT conditions. (B) GPC traces 
of synthesized PBOx and PEG45-b-PBOxn (2−7) (DMF, 65 °C). 
  
Gel-permeation chromatography (GPC) of the block copolymers 3−7 [N,N-dimethylformamide 
(DMF), 65 °C] showed unimodal peaks with narrow polydispersity index (PDI) free from the peak of 
the PEG macro-chain-transfer agent, indicating successful chain extension from the PEG chain-
transfer agent (Figure 2.2B). The molecular weight and DP of the PBOx block were estimated by 1H 
NMR integration using the methylene peak of PEG as a standard (Table 1 and Figure 2.3). The 
molecular weights obtained by GPC using polystyrene standards were consistently larger than those 
measured by 1H NMR analysis. Attempts to obtain MALDI−TOF mass spectra were unsuccessful. 
 
Table 2.1. Characterization of homopolymer (PBOx) 2 and PEG45-b-PBOxn Block 
Copolymers 3-7 
sample Mn (g/mol)
a 
DPn 
(PBOx)b 
Mn 
(g/mol)c 
PDIc Ka
fru 
 (M-1)d 
Ka
glu  
(M-1)d 
2  - - 21,400 1.06 643.3 14.5 
3  8420 38 23,100 1.04 - - 
4 9400 44 26,100 1.06 - - 
5 10020 48 28,300 1.06 - - 
6 10840 53 34,900 1.06 - - 
7 11640 58 43,200 1.10 420.1 9.9 
a The number average molecular weight determined by 1H NMR integration. b The number average degree of 
polymerization of PBOx determined by 1H NMR integration. c The number average molecular weight and 
polydispersity index obtained by GPC (DMF, 65 °C, 1 mL/min flow rate) using PS standards. d Association constants 
measured by the Wang's method.  
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Figure 2.3 1H NMR (600 MHz, DMSO-d6) spectra of block copolymers PEG45-b-PBOxn (3: n = 38, 
4: n = 44, 5: n = 48, 6: n = 53, 7: n = 58). The degree of polymerization of the PBOx block was 
calculated by comparing the integration of the benzyl signal of the PBOx (4.8 ppm) and the methylene 
signal of the PEG (3.5 ppm). 
 
Binding Constant of Homopolymer and Block Copolymers with Monosaccharides. To 
chracterize this binding, we performed Wang’s competitive binding assay to quantitate the binding of 
PBOx to monosaccharides.19 The absorption at 452 nm of the initial PBOx/Alizarin red S (ARS) 
complex ([boroxole]:[ARS] = 250:1) in a 9:1 (v/v) phosphate buffer/dioxane mixture (pH 7.4) shifted 
to 520 nm upon addition of fructose (0.5 M) and glucose (0.5 M), indicating the replacement of 
boroxole-bound ARS molecules with monosaccharides (Figures 2.4). The association constant Ka of 
PBOx was assessed by measuring the decrease in fluorescence emission of the PBOx/ARS complex 
caused by the replacement of ARS molecules bound to PBOx by monosaccharides. The measured Ka 
for homopolymer 2 was 643.3 M−1 for fructose and 14.5 M−1 for glucose; for the representative block 
copolymer 7, Ka = 420.1 M
−1 for fructose and 9.9 M−1 for glucose. These Ka values are comparable to 
the results reported for benzoboroxole- and boroxole-functionalized polymers17,18 indicating that 
boroxoles incoporated into the polymeric backbone exhibit binding to monosaccharides comparable 
tomthat of phenylboroxole. 
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Figure 2.4 (A) Absorbance of a ARS (8 × 10-5 M in pH 7.4, 0.1 M phosphate buffer) with PBOx (0.02 
M) (B) ABS (8 × 10-5 M) with 0.02 M PBOx and 0.5 M fructose (C) 8 × 10-5 M ARS with 0.02 M 
PBOx and 0.5 M glucose. 
 
Self-Assembly of Block Copolymers. The monosaccharide-responsive behavior of PBOx at 
neutral pH makes this polymer an ideal candidate for constructing stimuli-responsive block 
copolymers that self-assemble into polymersomes capable of encapsulating pharmaceutical cargos 
such as insulin. To the best of our knowledge, there have been no reports describing boronic acid-
containing block copolymers that form polymer vesicles and exhibit sugar-responsive release of cargo 
in water at physiologically relevant pH. To guide the self-assembly of block copolymers into 
polymersome formation, the ratio between the hydrophilic and hydrophobic blocks had to be 
optimized. Therefore, we studied the self-assembly behavior of our block copolymers in water. Self-
assembled structures of block copolymers 3−7 were prepared by the selective solvent method: to a 
THF solution (2 mL) of PEG-b-PBOx (0.5 wt %) was slowly added distilled water at a rate of 2 mL/h 
with stirring until the water content reached 66%. The resulting suspension was dialyzed against water 
for 24 h and then characterized by transmission electron microscopy (TEM) and dynamic light 
scattering (DLS). 
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Figure 2.5 (A−C) TEM images of micelles and polymersomes formed by self-assembly of PEG-b-
PBOx in water. (A) Spherical micelles of 3. (B) Cylindrical micelles of 4 [average diameter (Dav) = 42 
nm, PDI = 1.20]. (C) Polymersomes of 7. (D) Size distributions and (inset) autocorrelation functions 
of polymersomes of 5−7 in water. Dav (PDI) for polymersomes: 5, 114 nm (0.103); 6, 232 nm (0.102); 
7, 387 nm (0.064). 
 
A series of block copolymers 3−7 showed self-assembly behavior similar to that of conventional 
amphiphilic block copolymers: as the DP of the sugar-responsive PBOx block increased, the 
morphology of the self-assembled structures changed from spherical micelles (3, Figure 2.5A) to 
cylindrical micelles (4, Figure 2.5B) to polymersomes (Figure 2.5C). Interestingly, block copolymers 
5−7 formed polymersomes whose diameters, as measured by DLS, were strongly dependent on the 
number of boroxole repeating units in the PBOx block. As shown in Figure 2.5D, the average 
diameter determined by DLS ranged from 114 to 387 nm with increasing DP of the PBOx block (for 
TEM images, Figure 2.6). All of the micelles and polymersomes were stable in water for more than 3 
months, as evidenced by TEM and DLS experiments showing no change in morphology or diameter. 
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Figure 2.6 TEM images of polymersomes of (A) 5 (PEG45-b-PBOx48), (B) 6 (PEG45-b-PBOx53), and 
(C) 7 (PEG45-b-PBOx58). 
 
Glucose-Responsive Behavior of the Polymersomes. The sugar-responsive disassembly of 
polymersomes of PEG-b-PBOx was examined by measuring the turbidity of polymersome solutions 
in the presence of monosaccharides at neutral pH (Figure 2.7). The optical transmittance at 580 nm of 
the turbid suspension of polymersomes of 7 was monitored in the presence of monosaccharides. With 
0.2 M fructose, the turbidity of the polymersome solution (pH 7.4) decreased as a result of 
disassembly of the polymersomes into block copolymers caused by binding of monosaccharides to 
PBOx. This sugar-responsive bahavior of polymersomes of 7 in the presence of monosaccharides was 
also observed from the disappearance of polymersomes after addition of monosaccharides (0.2 M 
fructose) in the DLS study (Figure 2.8). The disassembly of polymersomes in the presence of glucose 
was expected to be slower and required a higher concentration of sugar, as suggested by the Wang’s 
assay with 7 (Table 2.1). Upon dialysis against pure water, a polymersome solution of 7 formed 
precipitates due to the dissociation of boronate esters of saccharide molecules and boroxoles, 
indicating the reversible interaction between boroxoles and saccharides. 
 
Figure 2.7 Optical transmittance profiles of the polymersome solution of 7 in the presence of 
monosaccharides. 
A B C 
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Figure 2.8 (A) Scattered light intensity and diameter change of polymersome solution of 7 in the 
presence of fructose (0.2 M) in phosphate buffer (pH = 7.2). (B) A representative TEM image of 
polymersomes of 7 without fructose. (C) A representative TEM image of the same polymersomes in 
the presence of fructose (The sample was taken 15 min after introduction of fructose to the 
polymersome solution. Before TEM sampling, the solution was diluted with water and dialyzed 
against water for 24 h.). 
 
Fluorescein-Labeled Insulin Encapsulation in the Polymersome. To demonstrate the possibility 
of using these saccharideresponsive polymersomes as sugar-responsive smart nanocontainers for 
water-soluble molecules, we encapsulated fluorescein isothiocyanate (FITC)-labeled human insulin 
(F-insulin) within polymersomes. For encapsulation, an aqueous solution of F-insulin (0.1 mg/mL in 
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phosphate buffer) was slowly added to the THF solution of 7 to induce self-assembly of block 
copolymers into polymersomes in the presence of F-insulin. The resulting polymersome solution was 
purified by dialysis (MW cutoff of 13 000 Da) against phosphate buffer for 2 days. To remove any 
unencapsulated F-insulin, polymersome solutions (Dav = 340 nm, PDI = 0.204) were further purified 
using size-exclusion chromatography (Sephadex G-50). Encapsulation of F-insulin within 
polymersomes was confirmed by laser confocal fluorescence microscopy (LCFM), which showed 
green fluorescence emanating from the polymersomes (Figure 2.9). After purification, polymersomes 
encapsulating F-insulin were stable in acidic solution (1 < pH < 7) for at least 24 h without any 
disassembly or aggregation of polymersomes, as monitored by DLS. 
 
A                          B                          C 
 
 
 
 
 
 
Figure 2.9 LCFM images of polymersomes of 7 encapsulating FITC-labeled human insulin : (A) 
dark-field (B) bright-field (C) merged. Scale Bar: 5 μm. 
 
Feasibility of the Polymersomes as Insulin Delivery Vehicles in Physiologically Relevant 
Conditions. As summarized in Figure 2.1, encapsulated F-insulin was released from polymersomes in 
response to the presence of monosaccharide in the medium (pH 7.4). The solution of polymersomes of 
7 (1 mL) encapsulating F-insulin was charged in a dialysis bag (MW cutoff of 10 000 Da), which was 
then dialyzed against 100 mL of phosphate buffer containing fructose (0.1 M) or glucose (0.3 M). 
During dialysis, a fraction of the buffer solution was taken at intervals of 30 min for fluorescence 
measurements. The release of F-insulin from disassembled polymersomes was observed from the 
measurement of emission spectra (λmax = 518 nm), which showed an increase over the period of 
dialysis (Figure 2.10). Without monosaccharides, no fluorescence was observed during dialysis of 
polymersomes encapsulating F-insulin over the entire time period of dialysis, indicating that 
polymersomes of PEG-b-PBOx did not release the encapsulated insulin without triggering by 
monosaccharide binding. Also, the presence of nonbinding diols such as ethylene glycol in the 
medium (up to 1 M) did not cause significant disassembly of the polymersomes. The polymersomes, 
as examined by DLS, stayed intact during 2 days of dialysis in the presence of 1 M ethylene glycol. 
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As suggested by previous studies,17,18 nonreducing sugars such as α-methyl-D-mannopyranoside also 
induced disassembly of the polymersomes, as indicated by the release of F-insulin. In the presence of 
monosaccharides, 50% of the release of insulin from the polymersomes of 7 was achieved within 1.4 
h with 0.1 M fructose and 10.5 h with 0.3 M glucose. 
 
Figure 2.10 Release profiles of F-insulin from the polymersomes of 7 in the presence of 
monosaccharides and nonbinding diols. 
 
2.4 Summary 
In summary, we have synthesized a boroxole-based styrenic monomer that can be polymerized by 
the RAFT method. The controlled polymerization of the boroxole-based monomer 1 with a PEG-
based chain-transfer agent allowed us to synthesize well-defined monosaccharide-responsive block 
copolymers. By utilizing the sugar-responsive disassembly of polymersomes of PEG-b-PBOx in 
aqueous solution at neutral pH, we have demonstrated the monosaccharide-triggered disassembly of 
polymersomes to release encapsulated cargo molecules such as FITC-labeled insulin under 
physiologically relevant pH conditions. Encapsulated insulin was released from the polymersomes 
only in response to the presence of monosaccharides that bind to boroxole moieties. The boroxole 
containing polymers and block copolymers reported here may find applications in the development of 
sensors and drug delivery systems designed for glucose-related human diseases such as diabetes.  
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2.5 Experimental 
General Method. All reagents and chemicals were purchased from commercial sources and used as 
received. All reactions were performed under N2 unless otherwise noted. NMR spectra were recorded 
on a Varian VNMRS 600 spectrometer with CDCl3 and DMSO-d6 as a solvent. Molecular weights of 
block copolymers were measured on a Agilent 1260 Infinity GPC system equipped with a PL gel 5 
μm mixed B column (Polymer Laboratories)) and differential refractive index detectors. DMF was 
used as an eluent with a flow rate of 1 mL/min. A PS standard (Polymer Laboratories) was used for 
calibration. A Cary Eclipse Fluorescence Spectrophotometer was used for all fluorescence studies. 
The ARS fluorescence intensities were measured with an excitation wavelength of 468nm and an 
emission wavelength of 572nm. The insulin fluorescent intensities were measured with excitation 
wavelength of 495 and emission wavelength of 518 nm. Transmission electron microscopy (TEM) 
was performed on a JEOL 1400 microscope at an acceleration voltage of 120 kV. Sample specimens 
were prepared by placing a drop of the solution on a carbon-coated Cu grid (200 mesh, EM science). 
After 30 min, the remaining solution on a grid was removed with a filter paper, and the grid was air-
dried for 8 h. Dynamic light scattering (DLS) experiments were carried out on a BI-200SM equipped 
with a diode laser (637 nm, 4 mW). All DLS data were handled on a Dispersion Technology Software 
(Brookhaven Instruments). Optical transmittance of the solutions was measured on a on a JASCO V-
670 UV-Vis spectrophotometer equipped with a thermostat sample holder with a magnetic stirrer. % 
Transmittance at 580 nm was used to calculate the optical transmittance (O.T) of the solution by the 
following equation. O.T = 1 – ((Tbuf – Tsol)/Tbuf) where Tbuf was the % transmission of the buffer at 
580 nm and Tsol was the % transmittance of the solution at the same wavelength. Confocal Laser 
Scanning Fluorescence Microscopy (CLSM) was performed on a FluoView 1000 Confocal 
Microscope (Olympus).  
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Synthesis of Styreneboroxole 1.  
3-bromo-4-hydroxymethylbenzonitrile (3). 3-bromo-4-bromomethylbenzonitrile (2) (11.6 g, 42.5 
mol) was added to a suspension of CaCO3 (18.3 g) in dioxane/water (2:3 v/v, 350 mL). This mixture 
was stirred at 100 °C for 24 h. After cooling to room temperature, the reaction mixture was extracted 
with diethyl ether (100 mL, 3 times). The combined organic phase was washed with brine and water. 
The organic layer was dried over anhydrous sodium sulfate. After solvent removal with a rotavap, the 
resulting solid was recrystallized in CH2Cl2/MeOH (95:5 v/v). Colorless crystalline solid was 
obtained. Yield 8.1 g (89 %). 1H NMR (600 MHz, CDCl3) δ 7.81 (s, 1H), 7.69 (d, J = 7.8 Hz, 1H), 
7.64 (d, J = 7.8 Hz, 1H), 4.79 (s, 2H); 13C NMR (150 MHz, CDCl3) δ = 145.4, 135.4, 131.2, 128.4, 
121.9, 117.3, 112.5, 64.2; MS (EI) calcd. for C8H6O1Br1N1 212.04; found 212.03.  
3-Bromo-4-((tert-butyldimethylsilyloxy)methyl)benzonitrile (4). A TBDMS-Cl (6.9 g, 46 mmol) in 
dry DMF solution (80 mL) was added dropwise to a 3-bromo-4-hydroxymethylbenzonitrile (3) (8.1 g, 
38.3mmol) and imidazole (6.5 g, 95.8 mmol) in dry DMF solution. The reaction mixture was stirred at 
room temperature for 20 h. The reaction was quenched by adding water (50 mL) and the reaction 
mixture was extracted with diethyl ether (100 mL) three times. The combined organic layer was 
washed with brine and water. After drying the solution with anhydrous MgSO4, the filtered solution 
was concentrated by removing the solvent with a rotavap. A white solid was obtained. The purity was 
checked by 1H NMR and the resulting compound was used without further purification. Yield 11.68 g 
(93.1%). 1H NMR (600 MHz, CDCl3) δ 7.78 (d, J=1.6 Hz, 1H), 7.69 (d, J = 7.8 Hz, 1H), 7.64 (dd, J = 
1.6Hz and 7.8 Hz, 1H), 4.73 (s, 2H), 0.96 (s, 9H), 0.15 (s, 6H); 13C NMR (150 MHz, CDCl3) δ = 
151.6, 140.4, 136.4, 133.3, 126.3, 122.9, 117.3, 69.7, 31.2, 23.7, -5.3; MS (ESI) calcd. for 
C14H20O1Br1N1Si1 [M+Na]
+ 349.30; found 349.78. 
3-Bromo-4-((tert-butyldimethylsilyloxy)methyl)benzolaldehyde (5). Compound 4 (11.68g, 35.8 
mmol) was dissolved in 100ml dry toluene. Then, the solution was cooled to 0 °C in an ice/water bath. 
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To this cooled solution was added a toluene solution of DIBAL-H (1 M, 60 mL) via a cannula with 
stirring. The reaction mixture was stirred at 0 °C for 3 h. The reaction was quenched by adding 
methanol dropwise (60mL), dilute HCl (1 M), and THF. The organic layer was collected, washed with 
brine, and dried with anhydrous MgSO4. After filtration, the filtered solution was concentrated on a 
rotavap. The crude mixture was purified by silica gel column chromatography (hexane:ethyl acetate 
15:1 v/v). Colorless oil was obtained. Yield 10.1 g (83.0 %). 1H NMR (600 MHz, CDCl3) δ 9.79 (s, 
1H), 7.84 (s, 1H), 7.69 (d, J = 7.8 Hz, 1H), 7.60 (d, J = 7.8 Hz, 1H), 4.61 (s, 2H), 0.82 (s, 9H), 0.16 (s, 
6H); 13C NMR (150 MHz, CDCl3) δ = 191.5, 147.2, 136.4, 132.7, 128.7, 127.8, 121.4, 64.6, 25.9, 
19.3, -5.4; MS (ESI) calcd. for C14H21O2Br1Si1 [M+H]
+ 329.30; found 329.81. 
3-Bromo-4-((tert-butyldimethylsilyloxy)methylstyrene (6). Methyltriphenylphosphonium bromide 
(14.2 g, 39.8 mmol) was dissolved in dry THF (300 mL). The flask was vacuumed and refilled with 
N2 three times. A dry THF solution of potassium t-butoxide (5.2 g, 45 mmol) added to the flaks via a 
syringe. A color change from white to reddish orange was observed and the mixture was stirred for 1 h. 
A THF solution of 5 (10.1 g, 31 mmol) was then added to the mixture. The mixture was stirred at R.T 
for 24 h. The solvent was removed under reduced pressure and the resulting crude mixture was 
dissolved in CH2Cl2. This solution was washed with water and brine. The organic layer was collected 
and dried with anhydrous MgSO4. After removing the solvent on a rotavap, the crude mixture was 
purified by silica gel column chromatography (hexane:ethyl acetate = 20:1). Colorless oil was 
obtained. Yield 7.8 g (72.2 %). 1H NMR (600 MHz, CDCl3) δ 7.55 (s, 1H), 7.51 (d, J = 7.8 Hz, 1H), 
7.36 (d, J = 7.8 Hz, 1H), 6.65 (dd, J1 = 10.8 Hz, J2 = 18.1 Hz, 1H), 5.74 (d, J = 18.1 Hz, 1H), 5.27 (d, 
J = 10.8 Hz, 1H), 4.74 (s, 2H), 0.98 (s, 9H), 0.14 (s, 6H); 13C NMR (150 MHz, CDCl3) δ = 134.2, 
132.5, 129.9, 124.2, 122.1, 119.7, 115.7, 109.2, 59.1, 20.4, 12.9, -5.4; MS (ESI) calcd. for 
C15H23O1Br1Si1 [M+Na]
+ 350.33; found 350.77. 
3-Bromo-4-((methoxymethoxy)methyl)styrene (7). Compound 6 (7.8 g, 24 mmol) was dissolved in 
methanol (150 mL). A few drops of conc. HCl was added to this solution, and the solution was stirred 
at room temperature for 30 min. The reaction mixture was extracted with diethyl ether 3 times. The 
combined organic phase was washed with brined and water, and dried with anhydrous MgSO4. After 
filtration and evaporation of the solvent, white crystalline solid was obtained. Purity of this compound 
was checked with 1H NMR. This solid, 3-bromo-4-hydroxymethylstyrene was used for the next 
reaction without further purification. 3-bromo-4-hydroxymethylstyrene (5.0 g, 23.4 mmol) was 
dissolved in dry THF (20 mL) and the solution was cooled to 0 °C. To this cooled solution was added 
at once sodium hydride (60 wt % dispersed in mineral oil, 1.09 g, 25.7 mmol). The reaction mixture 
was stirred at 0 °C for 20 min. A THF solution of methoxymethyl chloride (2.13 mL, 28 mmol in 15 
mL THF) was added dropwise via a syringe. The reaction mixture was warmed to room temperature 
and stirred for 2 h at room temperature. Then, the reaction was further proceed at 70 °C for 3 h. The 
22 
 
reaction was quenched by adding 10 % (w/w) aqueous solution of Na2CO3. The quenched reaction 
mixture was concentrated on a ratavap and the crude mixture was diluted with CH2Cl2. This solution 
was extracted with water three times. After drying the organic phase with anhydrous MgSO4, the 
solvent was removed on a rotavap. The crude compound was further purified by silica gel column 
chromatography (hexane:ethyl acetate = 15:1). The product was obtained as colorless oil. Yield 4.4 g 
(73.0%). 1H NMR (600 MHz, CDCl3) δ 7.60 (d, J=1.6 Hz, 1H), 7.44 (d, J = 7.8 Hz, 1H), 7.34 (dd, J = 
1.6 Hz and 7.8 Hz, 1H), 6.64 (dd, J1 = 10.8 Hz, J2 = 18.1 Hz, 1H), 5.76 (d, J = 18.1 Hz, 1H), 5.29 (d, 
J = 10.8 Hz, 1H), 4.76 (s, 2H), 4.66 (s, 2H), 3.43 (s, 3H); 13C NMR (150 MHz, CDCl3) δ = 143.4, 
135.4, 131.0, 128.8, 122.2, 117.3, 112.5, 96.4, 68.2, 55.6; MS (ESI) calcd. for C15H23O1Br1Si1 
[M+Na]+ 350.33, found 349.77. 
4-vinylboroxole (1). Mg (1.0 g, 41.7 mmol) was placed in a two neck flask equipped with a reflux 
condenser. The flask was vacuumed and refilled N2 three times. Under N2 atmosphere, dry THF (70 
mL) was added to this flask. A bulk 7 (4.4 g, 17 mmol) was added to the flask slowly via a syringe. 
The reaction was initiated and preceded for 1 h. Then, the reaction was further stirred at 60 °C for 3 h. 
The reaction mixture was then cooled to -76 °C in a dry ice/acetone bath. To this cooled solution was 
added trimethyl borate (3.8ml, 34mmol) dropwise via a syringe. After addition, the reaction mixture 
was warmed up slowly to room temperature and stirred for 8 h at room temperature. The reaction was 
quenched by adding aqueous HCl (2 M, 35 mL). The organic layer was separated from the aqueous 
layer, which was extracted with CHCl3 (100 mL, 3 times). The CHCl3 layer was collected and 
combined. The combined organic solution was evaporated on a rotavap. The crude mixture was 
purified by silica gel column chromatography (hexane:ethyl acetate = 3:1 v/v). A white crystalline 
solid was obtained. Yield 2.26 g (83.0%). 1H NMR (600 MHz, DMSO-D6) δ 9.17 (s, 1H), 7.78 (d, 
J=1.6 Hz 1H), 7.60 (dd, J = 1.6 Hz and 7.8 Hz, 1H), 7.39 (d, J = 7.8 Hz, 1H), 6.82 (dd, J1 = 10.8 Hz, 
J2 = 18.1 Hz, 1H), 5.83 (d, J = 18.1 Hz, 1H), 5.27 (d, J = 10.8 Hz, 1H), 4.98 (s, 2H). 
13C NMR (150 
MHz, DMSO-d6) δ = 154.0, 137.2, 136.2, 128.9, 128.5, 122.0, 114.2, 70.3. HRMS calcd. for 
C9H9O2B1 160.0697, found 160.0695. 
RAFT Polymerization of 6-vinylboroxole.  
CTA-1 was synthesized according to the literature procedure.23 
CTA-2. methoxy poly(ethylene glycol) (Mn = 2000 g/mol, Aldrich) was used to synthesize a macro-
chain transfer agent.24 
1H NMR (600 MHz, CDCl3) δ 4.25 (t, 2H), 3.64(m, 178H), 3.38 (s, 3H), 3.26 (t, 2H), 1.70 (s, 6H), 
1.23-1.40 (m, 20H), 0.88 (t, 3H). 
Polystyrene boroxole (PBOx). 6-vinylboroxole (1) (200 mg, 1.25 mmol) and CTA-1 were charged in 
a Schlenk tube with a magnetic stir bar. This tube was vacuumed and charged with N2 three times. To 
this mixture was added 5 mL of dry THF. The solution was degassed by bubbling N2 for 15 min. A 
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THF solution of AIBN (0.2 mg, mmol in 0.2 mL) was added at once to this solution, which, then, was 
immersed into a preheated oil bath (75 °C). The Schlenk tube was sealed, and the polymerization was 
performed for 17 h at 75 °C. For kinetic studies, a fraction of the reaction mixture was taken via a 
syringe under N2. The conversion of 1 to PBOx was measured by taking integration of 
1H NMR 
signal. After polymerization, the reaction mixture was exposed to air and immersed in the ice-water 
bath. The solution was precipitated into cold diethyl ether. The precipitates were collected by filtration, 
which were washed profusely with CH2Cl2 and vacuum dried.  
Synthesis of Block Copolymers PEG-b-PBOx. The same procedure for PBOx polymerization was 
used for the synthesis of block copolymers using CTA-2 as a chain transfer agent.      
 
Table 2.2 Isolated yield of polymers and homopolymers after purification.a 
a all polymerization was performed with 100 mg of monomer 1. b CTA efficiency was calculated with the 
isolated yield and the theoretical yield calculated by assuming all CTA being used for polymerization. 
 
Preparation of Micelle and Polymersome Solutions. Doubly distilled water (MilliQ, 18.1 MΩ) was 
used throughout the experiments. A typical procedure is described: PEG44-b-PBOx58 (10 mg) was 
dissolved in THF (2 mL) in a 15 mL capped vial with a magnetic stirrer. The solution was stirred for 3 
h at room temperature. A syringe pump was calibrated to deliver water at a speed of 2 mL/h. The vial 
cap was replaced by a rubber septum. 4 mL of water was added to the organic solution with vigorous 
stirring (850 rpm) by a syringe pump with a 5 mL syringe equipped with a steel needle. The remaining 
sample [1]:[CTA]:[I] Conversion (%) 
DPn 
(1H NMR) 
Yield 
(mg)a 
CTA efficiency 
(%)b 
2 100:1:0.1 43 - 40 - 
3 100:1:0.2 43 38 34 79 
4 100:1:0.2 47 44 32 68 
5 100:1:0.2 53 48 38 71 
6 100:1:0.2 52 53 35 67 
7 100:1:0.2 50 58 41 82 
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solution was subjected to dialysis (SpectraPor, molecular weight cut-off: 12,000−14,000 Da) against 
water for 24 h with a frequent change of water. The resulting suspension was collected from a dialysis 
bag. The diameter and morphology of polymersomes were studied by dynamic light scattering (DLS) 
and TEM. If necessary, the medium was exchanged from water to phosphate buffer (0.1 M, pH = 7.4) 
by using a centrifugal filter (Amicon, 100 KDa membrane cut-off) to remove water. The concentrated 
polymersome solution was re-suspended in phosphate buffer. 
Turbidity Test of Polymersomes. 5 mL of the polymersome solution (phosphate buffer, pH = 7.4) 
was charged in a quartx cuvette with a magnetic stir bar. To this solution was added fructose (180.16 
mg, 1 mmol) or glucose (270.3 mg, 1.5 mmol) at once. After complete dissolution of added sugar, the 
pH of the solution was readjusted to 7.4 by adding aqueous NaOH (1M). 2 mL of this solution was 
charged in a quartz cuvette with a magnetic stirrer. The absorbance at 580 nm was measured in every 
30 sec with a constant stirring. For measuring the scattered light intensity of the polymersome 
solution, the polymersome solution was stirred in the presence of 0.2 M fructose. A small portion 
(0.05 mL) of the polymersome solution was taken in every 5 min. This sample was instantly mixed 
with 1 mL of water. This diluted solution was used for the dynamic light scattering experiment. The 
scattered light intensity was measured at a fixed slit width throughout the measurement. 
Fluorescein Labeling of Insulin. The stock solution of insulin was obtained by dissolving 1 mg of 
insulin (Human insulin, Sigma) in 0.1 mL of 1 % acetic buffer and the working solution of insulin (0.1 
mg/mL) was obtained by diluting the stock solution by 100 folds into reaction buffer containing 50 
mM NaH2PO4, 100 mM NaCl (pH 7.5). The working solution of insulin was incubated with 10 molar 
equivalents of N-hydroxysuccinimidyl ester (NHS) fluorescein at room temperature with vigorous 
shaking for one and half hours. Reactions were implemented to dialysis with sterile deionized water to 
remove unreacted NHS-fluorescein overnight. 
Fluorescein-Labeled Insulin Encapsulation in the Polymersome. A PEG44-b-PBOx58 (8 mg) was 
dissolved in THF (2 mL) in a 15 mL capped vial with a magnetic stirrer. The solution was stirred for 3 
h at room temperature. A syringe pump was calibrated to deliver Fluorescein-labeled Insulin (F-Ins) in 
phosphate buffer (0.3 mg/mL) a speed of 2 mL/h. The vial cap was replaced by a rubber septum. 4 mL 
of F-Ins Insulin was added to the organic solution with vigorous stirring (850 rpm) by a syringe pump 
with a 5 mL syringe equipped with a steel needle. The remaining solution was subjected to dialysis 
(SpectraPor, molecular weight cut-off: 12,000−14,000 Da) against phosphate buffer for 2days with a 
frequent change of phosphate buffer. The resulting suspension was collected from a dialysis bag, and 
the suspension was then purified by size exclusion column chromatography (Sephadex G-50), which 
showed two green bands. The first band was collected and combined.  
Preparation and Analysis of Laser Confocal Fluorescence Microscopy Samples. The solution of 
polymersomes encapsulating fluorescein-labeled insulin was transferred onto chamlide (magnetic 
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chamber for 25 mm coverslip) and the images were taken directly. Confocal fluorescence images were 
acquired with FV1000 laser confocal fluorescence microscopy (Olympus) with the parameters of 
10 % laser power (370 HV), 1 Gain and 21 % offset and excitation and emission wavelength of 494 
and 518 nm, respectively. The images were viewed and processed with FV1000 viewer software 
(Olympus). 
Release of Fluorescein-Insulin from Polymersomes of PEG-b-PBOx. All experiments were 
performed by the method described: A solution of polymersomes of 7 (PEG45-b-PBOx58) (1 mL) 
encapsulating fluorescein-labeled insulin was subjected to a dialysis bag (SpectraPor, molecular 
weight cut-off: 8,000 Da), which was dialyzed against 100 mL of phosphate buffer with fructose (0.1 
M) or glucose (0.3 M) at pH = 7.4. The buffer outside the dialysis bag was taken at regular intervals to 
check the fluorescence emission (excitation wavelength of 495nm). Without monosaccharides in 
buffer, no fluorescence was observed from the buffer solution. 
Methodology for Screening PBOX (qualitative ARS assay) 25, 26, 27 
 
 
Scheme 2.2 Wang's competitive binding assay of boronic acids with carbohydrates using Alizarin Red 
S (ARS) as a colorimetric reporter. 
 
Methodology and Examples for Ka measurements by ARS method25, 26, 27  
Equations for association constant determinations. 
1/ΔIf = (ΔK poIoKeq1)
-1 /[R] + (ΔΚ poIo)
-1  (1) 
Where ΔK , po, Io are all the parameters of the fluorescence spectrophotometer, R is receptor (PBOx) 
and If is fluorescent intensity 
Q = [I]/[RI] = (IRI- I)/ (I - II ) (2) 
Where A is measured absorbance, IRI is intensity of the receptor-indicator (PBOx-ARS) complex, 
and II is intensity of free indicator. 
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P = [R0] – 1/ (Q Keq1) – [I0]/ (Q+1). (3) 
R0 is the total amount of PBOx and I0 is the total amount of ARS 
[S]/P = (Keq1/Keq)Q + 1 (4) 
where [S] is substrate concentration 
The equilibrium constant for PBOx – diol complex (Keq1) is obtained by ARS competitive experiments 
as following the procedure of Wang et al.,4 0.144 mM ARS solution was prepared in 0.1 M phosphate 
solution buffered at pH 7.4. Then, a PBOx was added to give solutions with a range of PBOx 
concentrations (1.25 x 10-3 - 1.27 x 10-2 M) and fluorescent intensities were measured with excitation 
wavelength of 468nm and emission wavelength of 572nm. The relationship between fluorescent 
intensity changes and equilibrium constant can be expressed using (Equation 1). The association 
constant for the ARS-PBOx (Keq1) is the quotient of the intercept and the slope in a plot of 1/ΔIf versus 
1/[R]. Two experiments were done to measure an average value of Keq1.  
 
Figure 2.11 ARS (1.145 × 10-4 M) fluorescent profile (λex=468 nm, λem=572 nm) with increasing 
concentration of ABS-PBOx complex (1.27 × 10-2 M, 5 × 10-3 M, 2.5 ×10-3 M, 1.67 × 10-3 M, 1.25 × 
10-3 M, 0 M) (B) Fluorescent intensity increase of ARS (1.145 × 10-4 M) in the presence of PBOx (pH 
7.4, 0.1m phosphate buffer). (C) 1/ΔIf versus 1/[R] for determination of ARS-PBOx (Keq1) in the 
presense ARS (1.145 × 10-4 M) PBOx (1.25 × 10-3– 1.27x10-2). Keq1 = 909.077 
 
Binding of PBOx with Glucose in the Three-Component Assay. The PBOx and ARS concentration 
were fixed at 3.1 × 10-3 M and 9.0 × 10-5 M, respectively in a 0.1 M phosphate buffer solution at pH 
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7.4 (solution A). 5mL of solution A was used to make 2.0 M glucose solution at pH 7.4 (solution B). 
By mixing the A and B solutions together, a range of glucose concentrations (0.13 – 0. 66 M) was 
obtained. The Keq is determined by equation 3 and 4 
 
Figure 2.12 (A) ARS fluorescent profile binding of PBOx (3.1 mM) with increasing glucose 
concentration (0 M, 0.13 M, 0.2 M, 0.25 M, 0.3 M, 0.35 M, 0.42 M 0.66 M, 1.0 M)  (B) [S]/P versus 
Q plot for binding of PBOx (3.1MM) with glucose (0.13-0.66) in the three component with the ARS 
solution (9 ×10-5 M). Keq = 14.52. 
 
Binding of PBOx with Fructose in the Three-Component Assay. The PBOx and ARS 
concentration were fixed at 3.1 × 10-3 M and 9.0 x 10-5 M, respectively in a 0.10 M phosphate buffer 
solution at pH 7.4 (solution A). 5mL of A solution was used to make 2.0 M fructose solution at pH 7.4 
(solution B). By mixing A and B solutions together, a range of fructose concentrations (0.00325 – 0.03 
M) was obtained. The Keq is determined by equation 3 and 4 
 
Figure 2.13 (A) ARS fluorescent profile binding of PBOx (3.1 mM) with increasing fructose 
concentration (0, 0.00325 M, 0.005 M, 0.008 M, 0.0105 M, 0.015 M, 0.02 M, 0.03 M)  (B) [S]/P 
versus Q plot for binding of PBOx (3.1 M) with fructose (0.005–0.03 M) in the three component with 
the ARS solution (9 ×10-5 M). Keq = 643.3. 
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Chapter 3. Glucose-Responsive Disassembly of Polymersomes of Sequence- 
Specific Boroxole-Containing Block Copolymers under Physiologically 
Relevant Conditions 
 
3.1 Abstract 
 Polymers containing organoboronic acids have recently gained interest as sugar-responsive materials 
owing to the reversible binding of saccharides to boronic acids, which triggers a change in the 
physical and chemical properties of these polymers, such as their water solubility. In particular, the 
ability of these polymers to bind glucose has attracted considerable attention because of the promise 
of these materials for the development of sensors and drug delivery systems for glucose-related 
human diseases, such as diabetes. We report here a new class of sugar-responsive polymers that are 
based on a sequence-specific copolymer of styreneboroxole and N-functionalized maleimide. The 
reversible addition-fragmentation and chain transfer (RAFT) polymerization of this pair of monomers 
ensured that a glucose-receptor alternates with a non-responsive solubilizing group throughout the 
sugar-responsive polymer chain. Due to the presence of hydrophilic solubilizing groups beween the 
solubility-switching boroxole moieties in the membrane-forming block, the polymersomes of the 
block copolymers responded to a lower level of glucose in the medium, resulting in diassembly of the 
bilayer membrane under a physiologically relevant pH and glucose-level. 
 
3.2 Introduction 
Stimuli-responsive polymers alter their physical and chemical properties in response to 
the external stimuli. These polymers have been highlighted as smart materials as their 
functions can be regulated in correspondence to the external stimuli, such as temperature, pH, 
light, and the presence of stimulant molecules.1-3 Polymers responsive to biomolecules are 
particularly interesting due to their potential applications such as sensors and drug delivery vehicles.4 
Polymers containing organoboronic acids recognize monosaccharides and saccharides by way of the 
reversible covalent bond formation between boronic acid and 1,2- and 1,3-diol compounds.5-7 In 
particular, the ability of these polymers to bind glucose has attracted considerable attention because of 
the promise these materials hold for the development of sensors and drug delivery systems in the 
treatment of glucose-related human diseases such as diabetes.8 Controlled radical polymerization of 
boronic acid-containing vinyl monomers has greatly improved the synthesis of sugar-responsive block 
copolymers with a well-defined architecture and molecular weight.9-12 These block copolymers self-
assemble into polymeric nanostructures, such as micelles and vesicles,13,14 which, along with self-
regulating hydrogels containing boronic acids as glucose receptors,15-17 exhibit great potential as drug 
delivery vehicles that can regulate drug release in accordance with the glucose level in the medium. 
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Of our particular interest is the use of polymer vesicles (polymersomes)18,19 formed by self-assembly 
of sugar-responsive block copolymers as an insulin delivery vehicle. Insulin encapsulated within the 
water-filled inner compartment of such vesicles can be released via sugar-responsive disassembly of 
polymersomes only when monosaccharides are abound in the surrounding solution.   
For applications including glucose sensors and insulin delivery vehicles, boronic acid adopted in 
a stimuli-responsive polymer should bind to glucose under physiological pH conditions. Under neutral 
pH conditions, sugar-bornoate ester hydrolyzes due partly to the bond angle strain around a trivalent 
B center, which requires a tetrahedral geometry to stablized the boronate ester.20,21 This can be 
achieved at neutral pH by adopting electron-withdrawing groups22,23 or electron-donating auxiliary 
groups to phenylboronic acids,24 which lowers the pKa value of the modified boronic acids. We 
recently synthesized a new class of monosaccharide-responsive polymers constructed by the 
reversible addition-fragmentation and chain transfer  (RAFT) polymerization of styreneboroxole.25 
Benzoboroxole (o-hydroxymethylphenylboronic acid) is capable of binding with 6-membered ring 
sugars (pyranosides) in aqueous solution at a neutral pH, such as the major isomer of glucose in 
water.26–30 The resulting poly(styreneboroxole) (PBOx) and its block copolymers with poly(ethylene 
glycol) as a hydrophilic block (PEG-b-PBOx) exhibited the monosaccharide-triggered change in 
solubility (from insoluble to soluble) in water at a neutral pH. We demonstrated that these well-
defined sugar-responsive block copolymers self-assembled into polymersomes, which showed 
monosaccharide-triggered disassembly of the bilayer membrane, resulting in release of the 
encapsulated insulin in phosphate buffer at a neutral pH. 
Although our results suggested that these sugar-responsive polymersomes have potential as insulin 
delivery vehicles in the treatment of diabetes, important challenges still remain to be addressed. 
Despite the enhanced binding of benzoboroxole to glucose at a neutral pH, the polymersomes of made 
of PBOx block copolymers only exhibited disassembly in the presence of a high concentration of 
glucose (> 0.3 M), an order of magnitude higher than the concentration of glucose typically found in 
hyperglycemia (11–20 mM). We reasoned that the requirement of a high glucose level for 
disassembly of these polymersomes, in part, originates from the fact that glucose can only reach 
boroxole moieties via slow diffusion, propagating from the outer stratum of the bilayer membrane of 
the polymersome. Unlike hydrogels, in which most glucose-recepting boronic acid groups are 
exposed to the aqueous environment, most of the boroxole groups in the polymersomes made of 
PBOx block copolymers are embedded within the bilayer membrane. 
We report a new class of sugar-responsive block polymers that are based on a sequence-specific 
copolymer of styreneboroxole and N-functionalized maleimide. The RAFT copolymerization of this 
pair of monomers ensured that, in the resulting stimuli-responsive polymer, a glucose receptor 
boroxole alternates with a non-responsive solubilizing group throughout the polymer chain. Due to 
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the presence of hydrophilic solubilizing groups between the solubility-switching boroxole moieties in 
the membrane-forming block, the bilayer membrane of these polymersomes are amenable to diffusion 
of glucose through the membrane, resulting in disassembly of the polymersome at a lower glucose 
level, close to the physiologically relevant concentration. Given their low toxicity to cells and 
compatibility with serum, the polymersomes of our block copolymers may find application as smart 
insulin delivery vehicles of which the release behavior is regulated by the glucose level in the 
surrounding medium. 
 
3.3 Result and Discussion 
 
Scheme 3.1 (A) Synthesis of sequence-specific block copolymers of styreneboroxole and N-
functionalized maleimide by the RAFT polymerization. (B) A schematic representation of sugar-
responsive behavior of block copolymers in water. 
 
Synthesis of Sequcnce-Specific Block Copolymers. To implement solubilizing groups in the 
sugar-responsive backbone in a controllable manner, we adopted an alternating copolymerization of 1 
and maleimide 2−5 with an N-functional group of varying degrees of hydrophilicity to synthesize the 
glucose-responsive polymer block (Scheme 3.1). The RAFT polymerization of these pairs of 
monomers with PEG-CTA, (Mn(PEG) = 2000 g/mol) yielded block copolymers in which the stimuli-
responsive block was composed of an alternating sequence of 1 and maleimide 2−5.31–33 In a typical 
procedure, an equimolar mixture of 1 and 4 was used for polymerization with PEG-CTA and AIBN 
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at 65 °C in THF ([1]:[4]:[AIBN]:[CTA] = 100:100:0.01:1).  The progress of polymerization was 
monitored by 1H NMR until the degree of polymerization (DPn) of 1 and 4 reached the required value. 
All polymerization was suspended before the conversion of monomers reached 70 %. 1H NMR 
analysis of the resulting block copolymers 1-alt-4n indicated equimolar incorporation of 1 and 4 into 
the stimuli-responsive block, suggesting a strong tendency for alternating polymerization of these 
monomers (Figure 3.7).34 The controlled nature of the RAFT polymerization of 1 and 4 was also 
observed by quenching the polymerization at different reaction times, resulting in a gradual increase 
in the DPn of 1 and 4 (Figure 3.1) over the reaction time. GPC experiments of the block copolymers 
showed a unimodal peak, without any trace of a residual PEG-CTA. The molecular weight 
determined by GPC was compared to the value calculated from 1H NMR integration, which showed a 
consistent overestimation, as we has previously observed with GPC results of PBOx and their block 
copolymers (Table 3.1).25 
 
Figure 3.1. 1H NMR (600 MHz, DMSO-d6) spectra of a series of block copolymers 1-alt-4n where the 
subscript n denotes the calculated degree of polymerization by comparing the integration of a and b 
by assuming the value of PEG (Mn = 2,000 g/mol, DPn = 45) signal (3.45 ppm). The inset shows GPC 
traces of 1-alt-4n block copolymers (n = 37 (dotted line), 45 (dashed line), 54 (solid line)).   
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Binding constant of block copolymer with monosaccharides. We measured the binding constant 
(Ka) of the synthesized boroxole-containing block copolymers to monosaccharides in aqueous 
solution using the Wang's competitive binding assay (Table 3.1).20,35 For example, the measured Ka 
values of the block copolymers 1-alt-445, as determined using Alizarin Red S (ARS) as a reporter for 
boroxole-monosaccharide binding, were 13.39 M-1 for glucose, and 526.1 M-1 for fructose in 
phosphate buffer (pH 7.4).  For 1-alt-250, Ka was 13.40 M
-1 for glucose and 541.3 M-1 for fructose. 
These values were close to the binding constants determined for benzoboroxole, and for boroxole-
containing polymers and block copolymers.25,26,36 These results indicated that the alternating sequence 
of styreneboroxole and maleimide in the polymer chain did not affect the binding between boroxole 
and monosaccharides.  
 
Table 3.1 Characterization of the block copolymers containing a sequence-specific block.   
sample Mn (g/mol)
a 
DPn  
(1-alt-MI)b 
Mn 
(g/mol)c 
PDIc Ka
fru 
 (M-1)d 
Ka
glu  
(M-1)d 
1-alt-230 10105 30 36,700 1.24   
1-alt-240 12806 40 40,140 1.28   
1-alt-250 15508 50 46,200 1.28  541.3 13.40 
1-alt-330 11456 30 38,510 1.30   
1-alt-335 13032 35 46,900 1.32   
1-alt-437 15293 37 51,300 1.30   
1-alt-445 18167 45   50,600   1.28  526.1  13.39 
1-alt-454 21400 54 71,180 1.26   
1-alt-565 28216 65 84,330 1.35   
1-alt-3/554 21400 54 66,440 1.30 550.1 13.20 
1-alt-626 10664 26 34,710 1.25   
       
a The number average molecular weight determined by 1H NMR integration. b The number average degree of 
polymerization of (1-alt-MI)n determined by 
1H NMR integration. cThe number average molecular weight and 
polydispersity index obtained by GPC (0.1% DMAC in DMF, 35 °C, 1 mL/min flow rate) using PS standards. d 
Association constants measured by the Wang's method (PBS, 10 % dioxane).  
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Self-assembly of block copolymers. Control of the architecture of a block copolymer is crucial for 
driving its self-assembly process in such that a nanostructure of the desired morphology is achieved. 
The RAFT alternating copolymerization of 1 and N-functionalized maleimides 2−5 in the presence of 
a PEG macro-chain transfer agent allowed us to synthesize amphiphilic block copolymers possessing 
a sequence-specific sugar-responsive block, of which the degree of polymerization was controlled by 
virtue of the controlled nature of polymerization. For example, a series of block copolymers 1-alt-2n 
exhibited a morphological transition from spherical/cylindrical micelles to polymersomes as the DPn 
of 1 and 2 in the sugar-responsive block increases from 20 to 50. The block copolymers prepared by 
the alternating copolymerization of 1 and maleimide having a hydrophilic oligo(ethylene glycol) units 
as a N-functional group (methoxyethyl for 3, methoxyethoxyethyl for 4, and 
methoxyethoxyethoxyethyl for 5) exhibited a similar morphological transition from micelles to 
polymersomes with increasing DPn of a sugar-responsive block (Figure 3.2 and Figure 3.3 ).  
 
 
Figure 3.2 TEM images of cylindrical micelles of (A) 1-alt-230, (B) 1-alt-330, (C) 1-alt-437, and (D)  
1-alt-550 
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Figure 3.3 TEM images of polymersomes of (A) 1-alt-250, (B) 1-alt-335, (C) 1-alt-445, (D) 1-alt-565, 
and  (E) 1-alt-3/554. 
 
 
Figure 3.4 Confocal laser fluorescence microscopy of polymersomes of 1-alt-3/554 encapsulating 
fluorescein-labeled insulin (A) dark field (B) merged (C) bright field images, respectively. scale bars 
5 μm. 
By observing the morphology of the self-assembled structures on transmission electron 
microscopy (TEM) and dynamic light scattering (DLS), we identified the optimal DPn of 1 and 
maleimide for the formation of polymersomes upon self-assembly for all series of block copolymers 
A 
C E 
B 
D 
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(Figure 3.3). The encapsulation of water-soluble molecules within the polymersomes was 
demonstrated using fluorescein-labeled insulin (F-insulin) as a guest. For encapsulation, a THF 
solution of block copolymer 1-alt-445 (5 mg/mL) was dispersed in an aqueous solution containing F-
insulin (1 mg/mL in phosphate buffer). After dialysis against water and repeated size exclusion 
chromatography (Sephadex G-50), the polymersome of 1-alt-445 encapsulating F-insulin was 
visualized using a confocal laser fluorescence microscopy (CLFM), which confirmed that the 
fluorescent guest molecules were well-contained within the polymersomes (Figure 3.4). The purified 
polymersomes of 1-alt-445 encapsulating F-insulin was stable for a period of 4 weeks at ambient 
temperature, as judged based on DLS and TEM observations.                                        
Glucose-responsive behavior of the polymersomes. The sugar-responsive disassembly of the 
polymersomes made of block copolymers was studied by measuring the turbidity of the polymersome 
solution in the presence of glucose in solution by using a UV-Vis spectrometer. When glucose was 
present in the surrounding solution, disassembly of light-scattering polymersomes, triggered by the 
binding of boroxole and glucose, resulted in an increase in the optical transmittance measured at 580 
nm. We examined the effect of the solubilizing group positioned between boroxole units in the sugar-
responsive block by changing the solubilizing group from the least hydrophilic (methyl for 1-alt-240) 
to the most hydrophilic group (methoxytethoxyethoxyethyl for 1-alt-565). In all cases, no change in 
optical transmittance was observed for more than 48 h at 36 °C in the absence of glucose in the 
solution, with the exception of the polymersomes of 1-alt-565, which disassembled completely by 24 h 
in phosphate buffer lacking glucose. At 0.03 M glucose in buffer (pH 7.6), the polymersome solution 
of 1-alt-250 exhibited virtually no disassembly after 24 h, indicating that the hydrophobic methyl 
group on maleimide had little effect on increasing the glucose-responsiveness and consequential 
disassembly of the polymersomes. In contrast, when the solubilizing group was switched to more 
hydrophilic oligo(ethylene glycol) groups, disassembly of the polymersome solutions of the 
corresponding block copolymers became noticeably faster. For comparison, the response time (tR) was 
defined as the time required for reaching 50 % transmittance at 580 nm at the given glucose 
concentration. As the number of ethylene glycol units increased from 1 to 2, the tR decreased from 
24.1 h for 1-alt-345 to 6.94 h for 1-alt-445 (Figure 3.5B). 
The most marked effect was observed with the polymersome solution of 1-alt-3/554, the block 
copolymer that was synthesized using an equimolar mixture of 3 and 5 as a maleimide in pair with 1 
to prevent complete dissolution of the block copolymer in buffer without glucose. The polymersome 
solution of 1-alt-3/554 showed a rapid increase of transmittance at 580 nm at a concentration of 0.03 
M glucose (tR = 2.15 h at 36 °C), indicating the enhanced binding between boroxole groups in the 
sugar-responsive block and glucose (Figure 3.5B). Compared to the glucose-triggered disassembly of 
PEG45-b-PBOx57 (1.84 h at 0.5 M glucose in phosphate buffer at pH 7.4), the polymersomes of 1-alt-
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3/554 exhibited disassembly at a concentration of glucose an order of magnitude lower that at which 
the block copolymers with a sugar-responsive block consisting of PBOx showed a glucose-responsive 
behavior. The turbidity test of the polymersome solution of 1-alt-3/554 revealed that the polymersomes 
respond to a glucose concentration as low as 0.01 M in phosphate buffer (pH 7.6) (Figure 3.5C).  
 
 
Figure 3.5 (A) A schematic illustration of glucose-triggered disassembly of polymersomes of sugar-
responsive block copolymers. (B) Optical transmittance change of polymersome solutions of block 
copolymers in the presence of 0.03 M glucose (phosphate buffer, pH 7.6, 36 °C). (C) Optical 
transmittance change of the polymersome solutions of 1-alt-3/554 at different concentrations of 
glucose. 
 
Considering that the measured Ka value of 1-alt-3/554 to glucose (13.2 M
-1) was nearly identical to 
the value reported for benzoboroxole and PEG-b-PBOx, we suspected that this enhanced disassembly 
of polymersomes arose from the alternating arrangement of a glucose-receptor and a hydrophilic 
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solubilizing group in the glucose-responsive block. The binding of glucose to boroxole groups 
surrounded by hydrophilic solubilizing groups may unwind the polymer chains by imparting 
additional hydrophilicity to the sugar-responsive block. This, in turn, would promote further diffusion 
of glucose through the bilayer membrane and essentially induce disassembly of the membrane into 
individual block polymers (Figure 3.5A). 
Feasibility of the polymersomes as insulin delivery vehicles in physiologically relevant 
conditions. To assess the feasibility of using these polymersomes as drug delivery vehicles that can 
respond to glucose levels under physiologically relevant conditions, we performed the turbidity test 
using rabbit serum (Sigma). Without glucose in serum, the polymersomes of PEG45-b-(1-alt-3/5)54 
showed excellent stability for 24 h at 36 °C; no indications of aggregation or disassembly of the 
polymersomes were found in the turbidity test and DLS experiments (Figure 3.6A). In the presence of 
0.03 M glucose, in contrast, disassembly of the polymersome was observed at a reduced rate (tR = 
7.71 h) compared to the glucose-responsive disassembly in buffer.  
 
Figure 3.6 (A) Disassembly of the polymersomes of PEG45-b-(1-alt-3/5)54 in serum (rabbit serum, 
36 °C) in the presence of 0.03 M glucose. (B) Release profiles of insulin from the polymersomes of 
PEG45-b-(1-alt-3/5)54 at different concentrations of glucose in phosphate buffer (pH 7.4). (C) Results 
of the cytotoxicity tests of solutions of PEG45-b-(1-alt-5)65 in HeLa cells after 18 h incubation. N = 3, 
mean ± SD. 
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The release of encapsulated guest F-insulin from the polymersomes of PEG45-b-(1-alt-3/5)54 was 
also investigated at different glucose concentrations in buffer (pH 7.4) (Figure 3.6B). The 
insulinencapsulating polymersomes of PEG45-b-(1-alt-3/5)54 were contained in a semipermeable 
membrane (MW cutoff 12 kDa), which was dialyzed against buffer containing the desired 
concentration of glucose for 24 h. As suggested by the results of the turbidity tests, encapsulated 
insulin was released from the polymersomes via glucose-triggered disassembly. The rate of release 
was proportional to the concentration of glucose in the medium as shown in Figure 4b. We also 
assessed the cytotoxicity of the block copolymer by using PEG45-b-(1-alt-5)65 as a model copolymer 
due to its solubility in the medium lacking monosaccharides. HeLa cells were incubated with an 
aqueous solution of the block copolymer at varying concentrations for 18 h. Higher than 90% cell 
viability was observed with up to 0.3 mg/mL of PEG45-b-(1-alt-5)65, suggesting that the block 
copolymer has low cytotoxicity (Figure 3.6C). 
 
3.4 Summary 
In summary, we synthesized a new type of glucose-responsive polymers possessing a sequence-
specific arrangement of styreneboroxole and N-functionalized maleimide by using alternating 
copolymerization of these monomers under the RAFT condition. Introduction of hydrophilic 
solubilizing groups, such as oligo(ethylene glycol) at positions adjacent to glucose-binding boroxole 
groups in the polymer chain, caused the resulting sequence-specific polymer to demonstrate a 
glucose-responsive solubility change in water at a reduced concentration of glucose (~ 0.02 M) in 
aqueous solution at neutral pH. The sequence-specific nature of the sugar-responsive polymer was 
suggested to play a role in enhancing the glucose-responsive behavior at a low glucose-level. 
Amphiphilic block copolymers constructed using this sequence-specific sugar-responsive polymer 
block self-assembled into polymersomes in water, which could encapsulate water-soluble molecules, 
such as fluorescein-labeled insulin, within their inner compartment. The encapsulated insulin was 
released only when glucose was present in the medium such as neutral pH buffer and serum, via the 
glucose-triggered disassembly of the polymersomes. Given their low cytotoxicity, serum 
compatibility, and sugar-reponsive behavior at a glucose level close to physiologically relevant 
conditions, our block copolymers and polymersomes may find application such as smart delivery 
vehicles for glucose-related diseases such as diabetes.  
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3.5 Experimental 
General Method. All reagents and chemicals were purchased from commercial sources and used as 
received. All reactions were performed under N2 unless otherwise noted. NMR spectra were recorded 
on a Varian VNMRS 600 spectrometer with CDCl3 and DMSO-d6 as a solvent. THF was distilled over 
Na/benzophenone before use. Toluene and DMF was distilled over CaH2. A Cary Eclipse 
Fluorescence Spectrophotometer was used for all fluorescence studies. The ARS fluorescence 
intensities were measured with an excitation wavelength of 468nm and an emission wavelength of 
572nm. The insulin fluorescent intensities were measured with excitation wavelength of 495 and 
emission wavelength of 519nm. Transmission electron microscopy (TEM) was performed on a JEOL 
1400 microscope at an acceleration voltage of 120 kV. Sample specimens were prepared by placing a 
drop of the solution on a carbon-coated Cu grid (200 mesh, EM science). After 30 min, the remaining 
solution on a grid was removed with a filter paper, and the grid was air-dried for 8 h. Dynamic light 
scattering (DLS) experiments were carried out on a BI-200SM equipped with a diode laser (637 nm, 4 
mW). All DLS data were handled on a Dispersion Technology Software (Brookhaven Instruments). 
Optical density of the solutions was measured on a on a JASCO V-670 UV-Vis spectrophotometer 
equipped with a thermostat sample holder with a magnetic stirrer. % Transmittance at 580 nm was 
used to calculate the optical transmittance (O.T) of the solution by the following equation. O.T = 1 – 
((Tbuf – Tsol)/Tbuf) where Tbuf was the % transmission of the buffer at 580 nm and Tsol was the % 
transmittance of the solution at the same wavelength. Confocal Laser Scanning Fluorescence 
Microscopy (CLSM) was performed on a FluoView 1000 Confocal Microscope (Olympus).  
 
 
 
Synthesis of ethylene glycol amine.37  Ethylene glycol methyl ether 9 (83 mmol) and p-
toluenesulfonyl chloride (25 g, 127 mmol) were dissolved in dry THF solution (150 mL) and the 
solution was cooled to 0oC under N2 in ice/ water. Triethylamine (20.36 mL, 146 mmol) was added 
dropwise to the reaction flask using a dropping funnel. The mixture was stirred for 10 h. To this 
mixture, a solution of NaHCO3 (10.0 g, 119 mmol) in water (100 mL) was added, followed by sodium 
azide (9.5 g, 146 mmol) while stirring. The content was then heated to distill off the THF and refluxed 
for 8 h. After cooling, the reaction mixture was extracted with ethyl acetate (3 x 70 mL). The organic 
1.TEA,THF,p-TsCl, 10h, r.t.
2. NaN3, NaHCO3,H2O, 8 h,reflux
1.PPh3, THF,10h, r.t.
2. H2O ,8 h
n
O
OH
n
O
N3
O
NH2n
9 10 11
9b : n=1
9c: n=2
9d : n=3
11b: n=1
11c: n=2
11d: n=3
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layer was washed with brine, dried over anhydrous magnesium sulfate and the organic solvent was 
evaporated on a rotavap. Colourless oil 10 was obtained. 
Compound 10 (55 mmol) and triphenylphosphine (21.77 g, 83 mmol) were dissolved in dry THF 
solution (300 mL). The reaction mixture was stirred at for 10 h. Then, H2O (50 mL) was added and 
the solution further stirred for 8 h under N2 at room temperature. The THF was evaporated and H2O 
(100 mL) was added to the mixture. The reaction mixture was extracted with Toluene (3 x 70 mL). 
The combined water layer was evaporated on a rotavap.  
Monoethylene glycol amine (11b) Colourless oil was obtained. Yield: 4.9 g (72%) 1H NMR (600 
MHz, D2O) δ 3.52 (t, 5.2 Hz, 2H), 3.40 (s, 3H), 2.80 (t, J = 5.2 Hz, 3H).  
Diethylene glycol amine (11c) Colourless oil was obtained. Yield: 6.9 g (70 %) 1H NMR (600 MHz, 
D2O) δ 3.61 (dd, J = 5.8, 3.3 Hz, 2H), 3.56 (dd, J = 5.5, 3.6 Hz, 2H), 3.52 (t, J = 5.2 Hz, 2H), 3.40 (s, 
3H), 2.88 (t, J = 5.2 Hz, 2H).  
Triethylene glycol amine (11d) Colourless oil was obtained. Yield: 11.1 g (82%) 1H NMR (600 MHz, 
D2O) δ 3.68 – 3.73 (m, 6H), 3.65 (dd, J = 5.6, 3.2 Hz, 2H), 3.60 (t, J = 5.4 Hz, 2H), 3.40 (s, 3H), 2.83 
(t, J = 5.4 Hz, 2H). 
Synthesis of maleimide38 
 
Methylmaleimide (2). Methylamine hydrochloride 11a (19.1 g, 280 mmol) was added to a solution of 
acetic acid (40 ml), maleic anhydride (20.0 g, 200 mmol) and potassium acetate (30.0 g, 300 mmol) 
and the mixture was stirred for 4 h at reflux temperature (110 oC). The reaction was cooled and 
quenched with water. The mixture was poured, slowly, on to the chilled saturated sodium bicarbonate 
solution (100 mL) and the mixture was extracted with diethyether (3 x 70 mL). The organic layer was 
washed with brine, dried over anhydrous MgSO4 and the organic solvent was evaporated on a rotavap. 
The crude mixture was filtered through alumium oxide using CH2Cl2 as an eluent. A white solid was 
obtained. Yield: 6.20 g (20%). 1H NMR (600 MHz, CDCl3) δ 6.70 (s, 2H), 3.02 (s, 3H); 
13C NMR 
(150 MHz, CDCl3) δ = 170.9, 133.3, 23.8; MS (EI) calcd. for C5H5NO2 111.03; found 110.0926.  
Monoethylene glycol maleimide (3).  Monoethylene glycol amine 11b (10.0 g, 133 mmol) in 20 mL 
R-NH2
maleic anhydride
Et2O
r.t., 1 h
NO O
R
11
NaOAC, AC2O
ref lux, 3 h
R
11a: CH3
11b: CH3OCH2CH2
11c: CH3(OCH2CH2)2
11d: CH3(OCH2CH2)3
11e: Phenyl
13
O
O NH OH
R
R
2: CH3
3: CH3OCH2CH2
4: CH3(OCH2CH2)2
5: CH3(OCH2CH2)3
6: Phenyl
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Et2O was added dropwise to maleic anhydride (14.36g, 146 mmol) in 100 mL Et2O. The reaction 
mixture was stirred at room temperature for 1h. The solid (monoethylene glycol maleamic acid) 
precipitated out of the reaction mixture was filtered off. The monoethylene glycol maleamic acid was 
dissolved in 150 mL of acetic anhydride and 1.2 g of sodium acetate was added to this solution. The 
mixture was then, refluxed for 2 h with stirring. The reaction was cooled and quenched with water; 
then, aqueous solution was extracted with Et2O (3 x 100 mL) and washed with brine. The organic 
layer was collected and dried with anhydrous MgSO4. After removing the solvent on a rotavap, the 
crude mixture was purified by silica gel column chromatography (hexane/ethyl acetate 5: 1 v/v). A 
white crystalline solid was obtained. Yield 16.09 g (78%). 1H NMR (600 MHz, CDCl3) δ 6.70 (s, 2H), 
3.72 (t, J = 5.6 Hz, 2H), 3.53 (t, J = 5.6 Hz, 2H), 3.32 (s, 3H). 13C NMR (150 MHz, CDCl3) δ = 170.8, 
134.3, 69.45, 58.8, 37.4; MS (ESI) calcd. for C7H9NO3 [M + Na
+ + Methanol] 209.06; found 209.725.  
Diethylene glycol maleimide (4) Diethylene glycol amine 11c (3.12 g, 26.2 mmol) in 10mL Et2O was 
added dropwise to maleic anhydride (2.34 g, 23.9 mmol) in 100 mL Et2O. The reaction mixture was 
stirred at room temperature for 1h and then the reaction mixture was extracted with water (3 x 50 mL). 
The collected aqueous solution was extracted with CH2Cl2 (3 x 50 mL) and washed with brine. The 
organic layer was collected and dried with anhydrous MgSO4. The combined organic solution was 
evaporated on a rotavap. The colourless oil was obtained. The diethylene glycol maleamic acid was 
added in 100 mL of acetic anhydride and 0.8 g of sodium acetate was added. The mixture was then, 
refluxed for 2 h with stirring. The reaction was cooled and quenched with water; then, aqueous 
solution was extracted with Et2O (3 x 100 mL) and washed with brine. The organic layer was 
collected and dried with anhydrous MgSO4. After removing the solvent on a rotavap, the crude 
mixture was purified by silica gel column chromatography (hexane/ethyl acetate 3:1 v/v). Colourless 
oil was obtained. Yield 1.67 g (35%). 1H NMR (600 MHz, CDCl3) δ 6.69 (s, 2H), 3.73 (t, J=5.8 Hz 
2H), 3.65 (t, J = 5.8 Hz 2H), 3.60 (t, J = 5.8 Hz, 2H), 3.49 (t, J1 = 5.8 Hz 2H), 3.34 (s, 3H); 
13C NMR 
(150 MHz, CDCl3) δ = 170.7, 134.3, 72.0, 70.0, 67.9, 59.1, 37.1; MS (ESI) calcd. for C9H13NO4 [M + 
Na]+ 222.08, [M + Na+ + Methanol] 254.08; found 221.74, 253.75. 
Triethylene glycol maleimide (5) Triethylene glycol amine 11d (4.2 g, 26.2 mmol) in 10 mL Et2O 
was added dropwise to maleic anhydride (2.34 g, 23.9 mmol) in 100mL Et2O. The reaction mixture 
was stirred at room temperature for 1h and then the reaction mixture was extracted with water (3 x 50 
mL). The collected aqueous solution was extracted with CH2Cl2 (3 x 50 mL) and washed with brine. 
The organic layer was collected and dried with anhydrous MgSO4. The combined organic solution 
was evaporated on a rotavap. The colourless oil was obtained. The diethylene glycol maleamic acid 
was added in 100 mL of acetic anhydride and 0.8 g of sodium acetate was added. The mixture was 
then, refluxed for 2 h with stirring. The reaction was cooled and quenched with water; then, aqueous 
solution was extracted with Et2O (3 x 100 mL) and washed with brine. The organic layer was 
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collected and dried with anhydrous MgSO4. After removing the solvent on a rotavap, the crude 
mixture was purified by silica gel column chromatography (hexane/ethyl acetate 2:1 v/v). Colourless 
oil was obtained. Yield 1.86 g (32%). 1H NMR (600 MHz, CDCl3) δ 6.68 (s, 2H), 3.70 (t, J=5.8 Hz 
2H), 3.59 (m, 8H), 3.50 (t, J = 5.8 Hz, 2H), 3.35 (s, 3H); 13C NMR (150 MHz, CDCl3) δ = 170.77, 
134.3, 72.1, 70.7, 70.7, 70.2, 68.0, 59.2, 37.3; MS (ESI) calcd. for C11H17NO5 [M + Na]
+ 266.11, [M + 
Na+ + Methanol] 298.11; found 265.83 , 297.80. 
Phenylmaleimide (6) Aniline (6.04g, 63.5 mmol) in 10 mL CHCl3 was added dropwise to maleic 
anhydride (5.66g, 57.7 mmol) in 65 mL CHCl3. The reaction mixture was stirred at room temperature 
for 1h. The solid (phenylmaleamic acid) precipitated out of the reaction mixture was filtered off. The 
phenylmaleamic acid was dissolved in 125 mL acetic anhydride and 1g of sodium acetate was added. 
The mixture was then, refluxed for 2 h with stirring. The reaction was cooled and quenched with 
water; then, aqueous solution was extracted with Et2O (3 x 100 mL) and washed with brine. The 
organic layer was collected and dried with anhydrous MgSO4. After removing the solvent on a rotavap, 
the crude mixture was purified by silica gel column chromatography (hexane:ethyl acetate = 9:1). A 
yellow solid was obtained. Yield 8.29 g (83 %). 1H NMR (600 MHz, CDCl3) δ 7.44 (t, J = 7.5 Hz 2H), 
7.34 (t, J = 7.5 Hz, 1H), 7.31 (d, J = 7.5 Hz, 2H) 6.81 (s, 2H); 13C NMR (150 MHz, CDCl3) δ = 169.3, 
134.3, 131.3, 129.3, 128.1, 126.2; MS (EI) calcd. for C10H7NO2 173.05; found 172.94. 
Synthesis of vinyl boroxole (1) 22 Vinyl boroxole was synthesized by the literature method. 
Synthesis of 2-(Dodecylthiocarbonothioylthio)-2-methylpropanoic acid (TC)39 TC was purchased 
from Aldrich and also synthesized by the literature method. 
Synthesis of TC-terminated poly(ethylene glycol) (PEG-CTA)40 TC (7.2 g, 20 mmol) and oxalyl 
chloride (8.6 mL, 100mmol) were added into 40mL dry CH2Cl2 and stirred at room temperature until 
gas evolution stopped. Excess reagents were then removed under vacuum, and the residue was 
redissolved in 80 mL dry CH2Cl2, followed by addition of methoxy poly(ethylene glycol) (Mn = 2000 
g/mol) (8 g, 4 mmol in 100mL dry CH2Cl2). The reaction was stirred for 24 h at room temperature and 
the mixture was concentrated before precipitation from an excess of cold Et2O. The crude polymer 
obtained by filtration was purified by redisolving in CH2Cl2, precipitated in Et2O, and dried under 
vacuum overnight. Yellow powder was obtained. 1H NMR (600 MHz, CDCl3) δ 4.25 (t, 2H), 3.64(m, 
178H), 3.38 (s, 3H), 3.26 (t, 2H), 1.70 (s, 6H), 1.23-1.40 (m, 20H), 0.88 (t, 3H). 
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RAFT Polymerization of 4-vinylboroxole and maleimide. 
 
Synthesis of block copolymers PEG-b-P(BOx-alt-MI)  Styreneboroxole 1 (100 mg, 0.625 mmol), 
maleimide (2-5) (0.625 mmol) and PEG-CTA (12.5 mg, 6.25 x 10-3 mmol) were charged in a Schlenk 
tube with a magnetic stir bar. This tube was vacuumed and charged with N2 three times. To this 
mixture was added 5 mL of dry THF. The solution was degassed by bubbling N2 for 15 min. A THF 
solution of AIBN (0.10 mg, 6.25 x 10-4 mmol in 0.10 mL) was added at once to this solution, which, 
then, was immersed into a preheated oil bath (65 °C). The Schlenk tube was sealed, and the 
polymerization was performed at 65 °C. After polymerization, the reaction mixture was exposed to air 
and immersed in an ice-water bath. The solution was precipitated into cold diethyl ether. The 
precipitates were collected by filtration, which were washed profusely with CH2Cl2 and dried in 
vacuum. 
Synthesis of block copolymers PEG-b-P(BOx-alt-3/5)n Styreneboroxole 1 (100 mg, 0.625 mmol), 
monoethylene glycol maleimide 3 (48.28 mg, 0.312 mmol), triethylene glycol maleimide 5 (75.9 mg, 
0.312 mmol) and PEG-CTA (12.5 mg, 6.25 x 10-3 mmol) were charged in a Schlenk tube with a 
magnetic stir bar. This tube was vacuumed and charged with N2 three times. To this mixture was 
added 5 mL of dry THF. The solution was degassed by bubbling N2 for 15 min. A THF solution of 
AIBN (0.10 mg, 6.25 x 10-4 mmol in 0.10 mL) was added at once to this solution, which, then, was 
immersed into a preheated oil bath (65 °C). The Schlenk tube was sealed, and the polymerization was 
performed at 65 °C. After polymerization, the reaction mixture was exposed to air and immersed in 
the ice-water bath. The solution was precipitated into cold diethyl ether. The precipitates were 
collected by filtration, which were washed profusely with CH2Cl2 and dried in vacuum. 
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Figure 3.7 Integration of the aromatic sign a, c of 1-alt-626 and integration of the benzyl signal b of 
the PBOx (4.8 ppm) approximately showed 8 : 2 even though Phenyl maleimide was added more than 
2 times. This result indicates that this polymer block is composed of the alternating sequence. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 3.8 1H NMR (600 MHz, DMSO-d6) spectrum 1-alt-2n. The degree of polymerization of the 1-
alt-2n block was calculated by comparing the integration of the benzyl signal b of the PBOx (4.8 ppm) 
and the methylene signals a of the PEG (3.6 ppm).  
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Preparation of Micelle and Polymersome Solutions. Doubly distilled water (MilliQ, 18.1 MΩ) was 
used throughout the experiments. A typical procedure is described: 1-alt-MIn (10 mg) was dissolved in 
THF (2 mL) in a 15 mL capped vial with a magnetic stirrer. The solution was stirred for 3 h at room 
temperature. A syringe pump was calibrated to deliver water at a speed of 2 mL/h. The vial cap was 
replaced by a rubber septum. 4 mL of water was added to the organic solution with vigorous stirring 
(850 rpm) by a syringe pump with a 5 mL syringe equipped with a steel needle. The remaining 
solution was subjected to dialysis (SpectraPor, molecular weight cut-off: 12,000−14,000 Da) against 
water for 24 h with a frequent change of water. The resulting suspension was collected from a dialysis 
bag. The diameter and morphology of polymersomes were studied by dynamic light scattering (DLS) 
and TEM.  
Dynamic light scattering (DLS) experiments 
 
 
 
 
 
 
 
 
 
 
Figure 3.9 (A) Size distribution (B) Autocorrelation functions of polymersomes in water. Dav (PDI) 
for polymersomes: 1-alt-335, 403.4 nm (0.219); 1-alt-445, 484.8 nm (0.207); 1-alt-565, 749.9 nm 
(0.122); 1-alt-3/554, 657 nm (0.153). 
 
Turbidity Test of Polymersomes. 10 mL of the polymersome solution (phosphate buffer, pH = 7.4) 
was charged in a 15 mL vial with a magnetic stir bar. To this solution was added glucose (0.1 mmol, 
0.2 mmol or 0.3 mmol) at once. After complete dissolution of added sugar, the pH of the solution was 
readjusted to 7.6 by adding aqueous NaOH (1M). 2 mL of this solution was charged in a quartz 
cuvette with a magnetic stirrer. The absorbance at 580 nm was measured in every 10 sec with a 
constant stirring. 
Turbidity Test of Polymersomes in serum. 5mL serum (Rabbit serum, Sigma) passed through 0.2μm 
syringe filter and 5 mL of the polymersome solution (phosphate buffer, pH = 7.4) were charged in a 
15 mL vial with a magnetic stir bar. To this solution was added glucose (54 mg, 0.3 mmol) at once. 
After complete dissolution of added sugar, the pH of the solution was readjusted to 7.4 by adding 
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aqueous NaOH (1M). 2 mL of this solution was charged in a quartz cuvette with a magnetic stirrer. 
The absorbance at 580 nm was measured in every 10 sec with a constant stirring 
MTT assay. HeLa cells were plated in 96 well plates (7 X 103 cells / well) and incubated in a 37 oC 
and 5% CO2 incubator for 24 hr. The fresh DMEM medium (10% FBS, 5% Antibiotics) was added to 
the cells and different concentrations of polymer were treated for 18hr. 0.5 mg/mL Thiazolyl blue 
tetrazolium bromide solution was added to the cells for 4h and then removed the medium. The cells 
were then collected in 200 μL of DMSO. This 96-well plate was then measured at 595nm with a 
microplate reader.   
Fluoresce in labelling of insulin. The stock solution of insulin was obtained by dissolving 1 mg of 
insulin (Human insulin, Sigma) in 0.1 mL of 1 % acetic buffer and the working solution of insulin (0.1 
mg/mL) was obtained by diluting the stock solution by 100 folds into reaction buffer containing 50 
mM NaH2PO4, 100 mM NaCl (pH 7.5). The working solution of insulin was incubated with 10 molar 
equivalents of N-hydroxysuccinimidyl ester (NHS) fluorescein at room temperature with vigorous 
shaking for one and half hours. Reactions were implemented to dialysis with sterile deionized water to 
remove unreacted NHS-fluorescein overnight. 
FITC-labelled Insulin encapsulation in the polymersome of 1-alt-3/554. A 1-alt-3/554 (10 mg) was 
dissolved in THF (2 mL) in a 15 mL capped vial with a magnetic stirrer. The solution was stirred for 3 
h at room temperature. A syringe pump was calibrated to deliver Fluorescein-labeled Insulin (F-
insulin) in phosphate buffer (1.0 mg/mL) a speed of 2 mL/h. The vial cap was replaced by a rubber 
septum. 4 mL of F-Insulin was added to the organic solution with vigorous stirring (850 rpm) by a 
syringe pump with a 5 mL syringe equipped with a steel needle. The remaining solution was subjected 
to dialysis (SpectraPor, molecular weight cut-off: 12,000−14,000 Da) against phosphate buffer for 1 
day with a frequent change of phosphate buffer. The resulting suspension was collected from a 
dialysis bag, and the suspension was then purified by size exclusion column chromatography 
(Sephadex G-50), which showed two green bands. The first band was collected and combined.  
Preparation and Analysis of Laser Confocal Fluorescence Microscopy Samples. The solution of 
polymersomes encapsulating fluorescein-labelled insulin was transferred onto chamlide (magnetic 
chamber for 25 mm coverslip) and the images were taken directly. Confocal fluorescence images were 
acquired with FV1000 laser confocal fluorescence microscopy (Olympus) with the parameters of 
10 % laser power (370 HV), 1 Gain and 21 % offset and excitation and emission wavelength of 494 
and 518 nm, respectively. The images were viewed and processed with FV1000 viewer software 
(Olympus) 
Release of F-insulin from polymersome of 1-alt-3/554. The polymersome sample (2mL) 
encapsulating fluorescein-labelled insulin was subjected to a dialysis bag (SpectraPor, molecular 
weight cut-off: 8,000 Da), which was dialyzed against 100 mL of phosphate buffer with glucose 
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(0.01~0.03 M) at pH = 7.4. The buffer outside the dialysis bag was taken at regular intervals to check 
the fluorescence intensity (excitation wavelength of 495nm). Without glucose in buffer, no 
fluorescence was observed from the buffer solution for a 24 h period. 
Methodology and examples for Keq measurements by ARS method
  
 
 
 
 
 
 
 
 
 
Equations for association constant determinations. 
1/ΔIf = (ΔK poIoKeq1)
-1 /[R] + (ΔΚ poIo)
-1  (1) 
Where ΔK , po, Io are all the parameters of the fluorescence spectrophotometer, R is receptor (P(Box-
alt-MI)) and If is fluorescent intensity 
Q = [I]/[RI] = (IRI- I)/ (I - II )  (2) 
Where A is measured absorbance, IRI is intensity of the receptor-indicator (P(Box-alt-MI) -ARS) 
complex, and II is intensity of free indicator. 
P = [R0] – 1/ (Q Keq1) – [I0]/ (Q+1)  (3) 
R0 is the total amount of P(Box-alt-MI)  and I0 is the total amount of ARS 
[S]/P = (Keq1/Keq) Q + 1  (4) 
Where [S] is substrate concentration 
 
The equilibrium constant for P(Box-alt-MI) – diol complex (Keq1) is obtained by ARS competitive 
experiments as following the procedure of Wang et al.,[4] 0.144 mM ARS solution was prepared in 0.1 
M phosphate solution buffered at pH 7.4. Then, a 1-alt-MIn was added to give solutions with a range 
of 1-alt-MIn concentrations (1.25 × 10
-3 - 1.27 × 10-2 M) and fluorescent intensities were measured 
with excitation wavelength of 468nm and emission wavelength of 572nm. The relationship between 
fluorescent intensity changes and equilibrium constant can be expressed using (Equation 1). The 
association constant for the ARS- 1-alt-MIn (Keq1) is the quotient of the intercept and the slope in a 
plot of 1/ΔIf versus 1/[R]. Two experiments were done to measure an average value of Keq1. 
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Figure 3.10 (A) ARS (0.144 mM) fluorescent profile (Exc. λ=468 nm, Em. λ=572 nm) with 
increasing concentration of ABS-1-alt-445 complex (1.27 × 10
-2 M, 5 × 10-3 M, 2.5 × 10-3 M, 1.67 × 
10-3 M, 1.25 × 10-3 M, 0) (B) 1/ΔIf versus 1/[R] for determination of ARS-1-alt-445 (Keq1) in the 
presence ARS (1.145 x 10-4 M) and 1-alt-445  (1.25 × 10
-3 - 1.27 × 10-2 M). Keq1 = 699.25 
 
Binding of 1-alt-MIn with glucose in the three-component assay 
The P(Box-alt-MI) and ARS concentration were fixed at 3.1 × 10-3 M and 9.0 × 10-5 M, respectively 
in a 0.1 M phosphate buffer solution at pH 7.4 (solution A). 5mL of solution A was used to make 2.0 
M glucose solution at pH 7.4 (solution B). By mixing the A and B solutions together, a range of 
glucose concentrations (0.13 – 1.0 M) was obtained. The Keq is determined by equation 3 and 4 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11 [S]/P versus Q plot for binding of 1-alt-445 (3.1m M) with glucose (0.13 – 1.0 M) in the 
three component with the ARS solution (9 × 10-5 M). Keq = 13.398  
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Binding of 1-alt-MIn with fructose in the three-component assay 
The 1-alt-MIn  and ARS concentration were fixed at 3.1 × 10
-3 M and 9.0 × 10-5 M, respectively in a 
0.10M phosphate buffer solution at pH 7.4 (solution A). 5mL of A solution was used to make 2.0 M 
fructose solution at pH 7.4 (solution B). By mixing A and B solutions together, a range of fructose 
concentrations (0.00325 - 0.03 M) was obtained. The Keq is determined by equation 3 and 4 
 
 
 
 
 
 
 
 
 
 
Figure 3.12 [S]/P versus Q plot for binding of 1-alt-445 (3.1 mM) with fructose (0.005 - 0.03 M) in 
the three component with the ARS solution (9 × 10-5 M). Keq = 526.14 
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